X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Jay Taylor

Jay Taylor Jay Taylor is Vice President of International Advocacy at PhRMA. Prior to Joining PhRMA, Jay was a partner at the international law firm, McDermott, Will & Emery, where he specialized in international trade policy, export controls and Foreign Corrupt Practices Act (FCPA) matters. Previously, Jay served as Associate General Counsel at the Office of the United States Trade Representative (USTR), where he managed and litigated numerous international trade disputes, and drafted and negotiated several free trade agreements. Mr. Taylor received his undergraduate degree from Princeton University, and a law degree from Tulane University.

Recent Posts

Trading fair means upholding the law: A focus on patents

By Jay Taylor  |    April 18, 2017
Patents are the linchpin of innovation. In the United States and other countries around the world, they provide temporary protection for new inventions. A fair, stable and predictable patent...   Read More

Enforcing unmet trade obligations protects U.S. innovation

By Jay Taylor  |    April 11, 2017
The United States leads the world in medical innovation, helping patients across the globe access the latest life-saving treatments and cures. Trade agreements with other nations serve as the...   Read More

IP protections found to be critical to life-science innovation and investment

By Jay Taylor  |    April 7, 2016
A new report by the Information Technology and Innovation Foundation (ITIF) has found intellectual property (IP) protections to be crucial to stimulating risk-taking and innovation. The study, How...   Read More

Past free trade agreements provide valuable lessons for future success

By Jay Taylor  |    March 8, 2016
Last week, the Senate Committee on Finance held a hearing to discuss free trade agreement implementation and lessons learned from past agreements. The hearing focused on recent examples where...   Read More

Canada’s innovation opportunity

By Jay Taylor  |    February 11, 2016
Next month’s visit of Prime Minister Justin Trudeau to Washington is a chance to strengthen a vital trade and investment partnership and to resolve problems left over by Canada’s previous...   Read More

Canada’s chance to reform its approach to innovation

By Jay Taylor  |    February 5, 2016
Intellectual property drives and sustains research, development and delivery of valuable new treatments and cures for patients who need them around the world. America’s world-leading...   Read More

Australia’s opportunity to lead the TPP forward

By Jay Taylor  |    September 18, 2015
New Australian Prime Minister Malcolm Turnbull is certainly going to have a busy autumn. As he works to form a new government, Australia must also strive to complete negotiations in the...   Read More

Prime Minister Abe’s Visit is an Important Step Toward Strengthening Innovation

By Jay Taylor  |    April 29, 2015
Today was an historic day for Japanese Prime Minister Shinzo Abe, who arrived in the U.S. on Sunday for a week-long visit and became the first Japanese leader to address a joint session of...   Read More

Negotiators Must Say “Aloha” to a 21st Century Trade Deal

By Jay Taylor  |    March 10, 2015
This week, chief negotiators from the 12 Pacific Rim countries currently negotiating the Trans-Pacific Partnership (TPP) agreement are gathering in Hawaii to continue deliberations surrounding this...   Read More

U.S. Trade Representative Continues the Vital IP Dialogue

By Jay Taylor  |    February 24, 2015
Understanding how intrinsic intellectual property (IP) is to the United States economy (innovative industries support more than a quarter of all jobs in the U.S.), the Office of the U.S. Trade...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates